Nobel laureate: Ethics debate unstilled by stemcell success

Nov 12, 2012 by Olivier Thibault
Japanese Kyoto University professor Shinya Yamanaka, who won the 2012 Nobel Prize in Medicine with John B. Gurdon of Britain, answers to journalists' questions in Paris. Yamanaka cautioned that stem cells could still spur sharp debate, despite his achievement in creating cells that are not derived from embryos.

Newly-crowned Nobel laureate Shinya Yamanaka on Monday cautioned that stem cells could still spur sharp debate, despite his achievement in creating cells that are not derived from embryos.

The Japanese scientist was interviewed on a trip to Paris after co-winning the 2012 Nobel Prize for Medicine last month alongside Britain's John Gurdon.

Yamanaka was lauded for "reprogramming" so that they return to a versatile primitive state, called stem cells.

Researchers hope that stem cells may one day provide lab-grown tissue to replenish organs damaged by accident or disease.

Only the very first steps have been taken along this road, but the mission has been boosted by Yamanaka's work, for it implies that culled from embryos—until now the most potent but also a highly controversial source—may no longer be needed.

But Yamanaka warned that his induced (iPS) are unlikely to escape a storm touching on the creation of life.

"Now we can avoid the use of , so it's good. However, we are facing new ," he told AFP.

The question, he said, lies with the creation of so-called —cells that give rise to sperm or eggs.

"Can we make sperm from blood and can we fertilise these oocytes (eggs)?" he asked. "We really need discussion in society about how much we can do about this new technology."

Yamanaka said scientists in Kobe had already applied to the Japanese authorities for permission to carry out the world's first iPS trial on humans, using cells on patients suffering from .

And, he said, Japan was pushing ahead with a stem cell bank, which was approved in July.

"In theory, we can make iPS cells from each patient. But it would be very expensive and take six months to prepare the cells from each patient. So in reality, we cannot do that," he said.

A stem cell bank would be a good alternative, said Yamanaka.

The idea is to choose donors whose is least likely to trigger rejection by a patient's immune system.

"We may be able to cover many patients by having only a handful of iPS stock, that's our plan," he said. "By our estimations, we identified 140 such specific donors, (and with these) we could cover up to 90 percent of the whole population."

Some scientists have been cautious about iPS technology, fearing that reprogramming errors as an adult cell is rewound to its infant state, using a batch of introduced genes, could cause tumours.

Yamanaka, 50, carried out his groundbreaking work in 2007, but was quick to pay tribute to Gurdon, who laid the conceptual foundations in 1962.

In 2007, "We thought maybe we will win the Nobel prize in the future if it goes" to clinical trials, he said.

"So we did not expect (it) at this time because it was too early. But we were awarded because of Sir John Gurdon and his discovery 50 years ago... Because of him I was very lucky to be awarded."

Explore further: The malaria pathogen's cellular skeleton under a super-microscope

add to favorites email to friend print save as pdf

Related Stories

Japan Nobel laureate gets washing machine as gift

Oct 19, 2012

Japan's Shinya Yamanaka may have won $1.2 million along with British researcher John Gurdon when the two were awarded the Nobel Prize for medicine earlier this month, but now he is also getting a new washing machine.

The future of stem cell research

Dec 08, 2010

Perhaps no single scientist has had a greater impact on stem cell research than Dr. Shinya Yamanaka. While most of his colleagues were looking for ways to grow human embryonic stem cells into replacement tissues for treating ...

Critical process in stem cell development identified

Jul 05, 2012

Scientists at the Gladstone Institutes have discovered that environmental factors critically influence the growth of a type of stem cell--called an iPS cell--that is derived from adult skin cells. This discovery offers newfound ...

Recommended for you

For resetting circadian rhythms, neural cooperation is key

16 hours ago

Fruit flies are pretty predictable when it comes to scheduling their days, with peaks of activity at dawn and dusk and rest times in between. Now, researchers reporting in the Cell Press journal Cell Reports on April 17th h ...

Rapid and accurate mRNA detection in plant tissues

17 hours ago

Gene expression is the process whereby the genetic information of DNA is used to manufacture functional products, such as proteins, which have numerous different functions in living organisms. Messenger RNA (mRNA) serves ...

For cells, internal stress leads to unique shapes

Apr 16, 2014

From far away, the top of a leaf looks like one seamless surface; however, up close, that smooth exterior is actually made up of a patchwork of cells in a variety of shapes and sizes. Interested in how these ...

User comments : 0

More news stories

Scientists tether lionfish to Cayman reefs

Research done by U.S. scientists in the Cayman Islands suggests that native predators can be trained to gobble up invasive lionfish that colonize regional reefs and voraciously prey on juvenile marine creatures.

Deadly human pathogen Cryptococcus fully sequenced

Within each strand of DNA lies the blueprint for building an organism, along with the keys to its evolution and survival. These genetic instructions can give valuable insight into why pathogens like Cryptococcus ne ...

Biologists help solve fungi mysteries

( —A new genetic analysis revealing the previously unknown biodiversity and distribution of thousands of fungi in North America might also reveal a previously underappreciated contributor to climate ...

Leeches help save woman's ear after pit bull mauling

(HealthDay)—A pit bull attack in July 2013 left a 19-year-old woman with her left ear ripped from her head, leaving an open wound. After preserving the ear, the surgical team started with a reconnection ...

Venture investments jump to $9.5B in 1Q

Funding for U.S. startup companies soared 57 percent in the first quarter to a level not seen since 2001, as venture capitalists piled more money into an increasing number of deals, according to a report due out Friday.